PULSE PRESSURE CLASSES AND DOSAGE OF THE MAIN GROUPS OF CARDIAC MEDICATIONS IN PATIENTS AT THE ANNUAL FOLLOW-UP PERIOD AFTER PACING
Abstract
Dose factor of the main groups of cardiac medications in five pulse pressure (PP) classes was studied in 220 patients (110 men and 110 women) at the annual stage after pacing, the average age 70 ± 9 years. Patients with the IV and V class of PP require the administration of higher doses of antiarrhythmics, diuretics, calcium channel blockers and ACE inhibitors.
In patients after pacing, the dose factor of the main groups of cardiac medications correlates with the PP classes and, the greater the PP class, the greater the dose rate of the medications. After pacing an increase of the dose factor of antiarrhythmic drugs (amiodarone) in the early period and diuretics and ß-blockers throughout the observation period with an increase in the PP class is required. The long term period of pacing contribute to reduction of the dose factor of antiarrhythmic drugs (amiodarone), Ca-channel blockers and ACE inhibitors in all classes of PP, to a greater extent - in II and III classes. The dose factor of anticoagulants, antiplatelet agents, ARBs and HMG CoA reductase inhibitors does not depend on the PP class and does not change over the entire observation period. Patients after pacing with IV and V classes of PP require the higher doses of antiarrhythmics, diuretics, Ca-channel blockers and ACE inhibitors.
Downloads
References
Higher pulse pressure/stroke volume index is associated with impaired outcome in hypertensive patients with left ventricular hypertrophy the LIFE study / [C. Mancusi, E. Gerdts, G. de Simone et al.]. // Blood Press. – 2017. – No. 26. – p. 150–155.
Beat-to-beat, ambulatory hour-to-hour, and home day-to-day variabilities in blood pressure, pulse pressure, and heart rate in comparison with each other and with target-organ damage / J. K. Johansson,
P. J. Puukka, R. Virtanen, A. M. Jula. // Blood Press Monit. – 2015. – No. 20. – p. 113–120.
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association / [M. Brignole, A. Auricchio, G. Baron-Esquivias et al.]. // Eur Heart J. – 2013. – No. 34. – p. 2281–329.
Ellims A. H. Restoration of blood pressure control with pacemaker implantation in a patient with bradycardia and resistant hypertension: A case report / A. H. Ellims, J. A. Mariani, M. P. Schlaich // International Journal of Cardiology. – 2013. – Volume 167. – Issue 2. – p. e38–e40.
Kolomytseva I. N. Funktsional'nyy klass khronicheskoy serdechnoy nedostatochnosti i medikamentoznoye soprovozhdeniye u patsiyentov na godovom etape posle implantatsii elektrokardiostimulyatorov / I. N. Kolomytseva. // Canadian journal of education and engineering. – 2015. – No. 12. – p. 569–578.
Maltseva M. S. Importance of QTc interval duration in pacing parameters optimization and therapeutic management of the patients with permanent cardiac pacing / M. S. Maltseva, D. E. Volkov. // The Journal of V. N. Karazin Kharkiv National University. Series «Medicine». – 2014. – No. 27. – p. 50–73.
Shanina I. V. Frequency of detached cardiac drugs prescribing in patients of different classes QRS complex duration on the permanent pacing background / I. V. Shanina, D. E. Volkov. // The Journal of
V. N. Karazin Kharkiv National University. Series «Medicine». – 2014. – No. 27. – p. 33–37.
Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice / [A. Mazza, S. Lenti, L. Schiavon et al.]. // Adv Ther. – 2017. – No. 34. – p. 975–985.
Copyright (c) 2017 The Journal of V. N. Karazin Kharkiv National University, series "Medicine"
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of V. N. Karazin Kharkiv National University, series Medicine has following copyright terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.